- •Pathophysiology tasks:
- •General doctrine of disease. Basic concepts of general pathology: norm, health. Definition by who. Disease.
- •Disease.
- •Conception of pathological process, pathological state, pathological reaction. Definition of typical pathological processes.
- •Typical pathological processes are the processes which are developed by similar laws, independently on reasons, localization, animals type and organism individual peculiarities.
- •Disease difference from health
- •3 Points of view:
- •Disease, biological and social factors are actual because human being is first of all social creature
- •4 Levels of diseases prescription:
- •5. Diseases classification principles:
- •8. Collapse. Comparative characteristics with shock. Aethiology and pathogenesis. Role of nervous and humoral mechanisms
- •9. Crash-syndrome -
- •10. Coma -
- •11. Informational aspects of cell injury. Pathology of signalization.
- •13. Programmed cell death (pcd)
- •3 Apoptosis phases:
- •14. Outcomes of apoptosis inhibiting and activation.
- •Classification.
- •4 Main types.
- •Classification.
- •16. The concept of primary and secondary alteration. Molecular mechanisms of cell injury. Lipid mechanisms role in alteration pathogenesis.
- •17. Free radicals and their role in pathological processes development.
- •19. Antioxidant mechanisms of cells. Antioxidant insufficiency.
- •19. Apoptosis and necrosis comparative characteristics.
- •20. Reactivity. Types. Dependence on sex.
- •23. Resistance. Passive and active resistance. Resistance and reactivity relationship.
- •25. Constitution, role in pathology, types classification.
- •26. Diatheses.
- •27. Stress, general adaptation syndrome.
- •28. Stress-inducing and stress-limiting systems. Diseases of adaptation.
- •29. Concept of “local microcirculatory disorders”. Some mechanisms.
- •30. Arterial hyperemia
- •2 Subtypes:
- •31. Venous hyperemia
- •32. Ishemia
- •33. Reperfusion syndrome
- •34. Stasis.
- •Variants:
- •35. Thrombosis and embolism. Thrombosis characteristics.
- •3 Main factors encouraging thrombi formation (Wirhow’s triad):
- •36. Embolism.
- •37. Embolism of pulmonary, systemic and portal circulation.
- •38. Microcirculation disorders typical forms:
- •39. Intravascular circulation disorders: rheological changings and changings of blood flow.
- •41. Microvascular tone disorders.
- •42. Extravascular disorders.
- •43. Concept of inflammation. Aethiology.
- •44. Inflammation stages, main signs and types.
- •Inflammation types (continuation).
- •45. Primary and secondary alteration.
- •46. Mediators and antimediators.
- •47. Circulatory changings during inflammation.
- •48. Fever aethiology. Pyrogens classification.
- •49. Fever stages. Fever reactions types.
- •50. Fever comparative characteristics with exogenous overheating and hyperthermia other forms.
- •50. Edemas. Classification. Oncotic and hydrostatic mechanism.
- •58. Anaemias. Erythrocytes regenerative and degenerative forms. Cells of pathological regeneration.
- •54. Anisocytosis, poikylocytosis, price-jonce’ curve movements on the right and on the left.
- •55. Blood loss.
- •56. Acute and chronic posthaemorrhagic anaemias.
- •57. Hereditary hemolytic anaemias.
- •3 Groups:
- •58. Acquired haemolytic anaemias.
- •59. Dyserythropoietic anaemias.
- •60. Aplastic and hypoplastic anaemias. Metaplastic anaemia. Myelophthysis.
- •2 Groups of factors:
- •2 Main pathogenetic mechanisms:
- •61. Cardiac arrhythmias.
- •62. Concept of arterial hypo- and hypertension.
- •63. Primary arterial hypertension.
- •2 Pathogenetical conceptions:
- •64. Secondary arterial hypertension.
- •65. Cardiac insufficiency.
- •2 Overloads types:
- •66.Heart failure myocardial form.
- •67. Coronary cirulation disorders. Reperfusion syndrome. Calcium paradox. Oxygen paradox.
- •68. Respiratory failure.
- •Probes which allow to determine one or another disorders type:
- •69. External respiratory failure. Dyspnea.
- •70. Hypoxies.
- •71. Appetite disturbance.
- •2 Main mechanisms:
- •72. Caries.
- •73. Periodontitis and parodontosis.
- •74. Hypo- and hypertonic gastric dyskinesias.
- •75. Heartburn, eructation, nausea, vomiting.
- •76. Hepatic failure. Classification. Functional hepatic tests.
- •77. Hepatic failure hepatic-vascular form.
- •78. Liver excretory function disorders. Jaundices. Liver functions
- •Proteinic exchange
- •Carbohydrates metabolism
- •Lipid metabolism
- •Pigment metabolism
- •Jaundices differentiated diagnosis
- •79. Haemolytic jaundice.
- •80. Hepato-cellular or parenchymatous jaundice.
- •81. Hepato-portal hypertension. Ascitis.
- •82. Urine amount qualitative and quantitative changings.
- •Urine relative density (weight) (in morning portion)
- •83. Urine pathological components. Protein
- •Leucocytes:
- •Cylinders
- •84. Proteinuria.
- •85. Renal acid-alkaline balance disorders
- •86. Adrenal glands pathology. Cortex acute and chronic insuffieiency.
- •87. Thyroid hypofunction.
- •88. Hypothyroidism.
- •89. General regularities in occurrence and development cns disorders. Pathological processes classification.
- •90. Pathological excitement and inhibiting in nervous centers.
- •I. Of pathological excitement:
- •II. Of pathological inhibiting:
- •91. Ephaptic effects.
- •92. Pain.
13. Programmed cell death (pcd)
The term “apoptosis” means from Greek “removal, separating”. Galen and Hippocrate designated “apoptosis” annual essential leaves fall. “Apo”- “complete”, “ptosis” – “falling down, loosing”. In 1972 Kerr, Willie and Curi have proposed to use the term “apoptosis” for cellular death special designation different from necrosis.
Many scientists put sign of equality between programmed cell death and apoptosis. But these terms have differencies.
1. PCD is embryogenesis characteristics mainly of embryonal neurons and cells of connective tissue, apoptosis – for postembryonic development (thymocytes, lymphocytes after glucocorticoids action, prostate after castration, atrophy et al.).
2. Main square for evnts at PCD is cytoplasma (changing of pattern-synthesizing proteins), apoptosis – nucleus (endonuclease activation). Proteins changing and endonuclease activation are primary manifestations of 2 cellular death types.
3 Main biochemical changings in nucleus: at apoptosis occur DNA internucleosomal degradation (ruptures); it is absent at PCD.
4. Biochemical changings in cytoplasm at PCD – lysosomal enzymes amount increasing, sometimes – synthesis of heat shock proteins; at apoptosis – lysosomal enzymes amount is not increased, sometimes – specific proteins synthesis.
5. Apoptic bodies phagocytosis at PCD lasts for several hours, at apoptosis – from several minutes from 1 hour.
3 Apoptosis phases:
1. Inductory – apoptosis triggering by signals accept; it is expressed differently dependently on cells types and triggering factors.
2. Effector – similar for all apoptosis types.
3. Degradation - similar for all apoptosis types.
Reasons:
I. 1. Specific stimuli action such as TNF, FAS, IL-1, 10, TGF-beta, INF-gamma, cytokines.
2. Radiations (low dosages).
3. Cytostatics.
4. Glucocorticoids.
5.Angiotensine.
6. ATP.
7. Morphine.
8. Temperature increasing.
9. Viruses.
10. Toxic agents.
They act at first stage.
II. Intracellular inducing agents:
Heat shock proteins.
p53.
Gene and protein of retinoblastome RB.
NO.
Free radicals.
Oxidants.
Ca, Pb and other genotoxic agents.
Growth factors lack or absence.
Hormones – estrogens in male sexual glands, androgens – in female.
Immediate genes of early reaction (c-fos, c-myc, c-jun).
Sufficient Ca-ions amount.
Sufficient ATP level.
Bcl-2.
P53 deficiency.
Bcl-2 – (from engl. “B-cellular leukemia/lymphoma-2”) – oncogen, locating in long arm of 18th chromosome (18q21), 3 exons. Proteins from 239 aminoacids. It is located in internal mitochondrial membrane, membranes of endoplasmic reticulum and nuclear membrane. There exists Bcl-2/Bax –rheostate: Bcl-2, Bcl-XL increasing lead to cellular survival; Bax, Bak, Bad increasing leads to death. Bcl-2 acts through peroxidative lipid oxidation inhibiting and Ca-ions level decreasing.
P53 – gene is in 17p13 (short arm of 17th chromosome). Nuclear protein, M 53 Da, phosphoproteid with 53000 Da. 2 forms: supressor – more stable, inhibits proliferation in G1/S checkpoint of mitotic cycle and triggers apoptosis; mutant – less stable, inhibits apoptosis. At radiation – apoptosis inhibiting through protein p21.
Apoptosis role in physiological processes:
cells amount constancy support;
organism and its parts shape determining (embryogenesis and tissues involution);
providing correct correlation in different-typed cells;
genetically defective and senescent (old) cells removal;;
growth and terminal differentiation;
thymocytes and lymphocytes selection;
in synaptogenesis – excessive parts removal in the places of future synaptic clefts;
fingers formation in embryos;
endometrium functional layer removal at the beginning of menstrual bleeding and others.
